Pharmacokinetic interaction study [Regulatives / Guidelines]

posted by nobody – 2016-05-20 11:40 (3688 d 07:05 ago) – Posting: # 16343
Views: 4,170

I would support this opinion (at least for EU), as the EMA DDI Guideline as of 2012 does not require formal BE testing. Why should this be more rigid for new FDCs?

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
133 visitors (0 registered, 133 guests [including 30 identified bots]).
Forum time: 18:45 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5